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INTRODUCTION
The apolipoprotein B mRNA-editing enzyme-
catalytic polypeptide-like 3G (APOBEC3G) is a po-
tent anti-HIV-1 cellular factor that modifies minus
strand viral DNA during reverse transcription, re-
sulting in either its degradation or its integration into
host chromosomal DNA as a hypermutated provirus
(1-3). The deleterious effect of APOBEC3G on HIV-1
comes from its packaging into progeny virions at the
stage of assembly in the viral replication cycle (4, 5).
HIV-1 Vif impedes the encapsidation of APOBEC3G
into nascent virions (6-9). In the APOBEC3G-
expressing cells such as a lymphocyte cell line named
H9 and peripheral blood mononuclear cells (PBMCs),
HIV-1 without functional vif gene is unable to grow
(10, 11), and therefore, these cells are called non-
permissive. Natural target cells of HIV-1 in infected
individuals are thought to be all non-permissive.
The non-permissive target cells, which have been
routinely used for biological and/or biochemical
studies on the interaction of Vif and APOBEC3G,
are of lymphocyte cell lineage. It has been well es-
tablished that transfection of lymphocytic cell lines
and primary lymphocytes with test DNAs are very
inefficient, and that reproducible results are difficult
to obtain. The APOBEC3G-positive cell lines with
high transfection efficiency were obviously required
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for molecular virological analyses of Vif and its tar-
get APOBEC3G. To the best of our knowledge, how-
ever, there has been only one reported monolayer
cell line which steadily expresses APOBEC3G and
is very susceptible to transfection (8). In this study,
we have established stable APOBEC3G-positive 293T
cell lines, which are very sensitive to and suitable for
transfection analysis. We show here clearly that the
cell line designated 293T/A3G-C1 produced a much
higher level of APOBEC3G functional against HIV-1
than that by natural target cells.
MATERIALS AND METHODS
Cells
A monolayer cell line 293T (12) was maintained
in Eagles’s minimal essential medium containing
10% heat-inactivated fetal bovine serum. A lympho-
cytic cell line H9 (13) was maintained in RPMI-1640
medium containing 10% heat-inactivated fetal bovine
serum. Human PBMCs were prepared essentially as
previously described (14).
Transfection
293T cells were transfected by the calcium-
phosphate co-precipitation method as previously re-
ported (15).
Western immunoblotting
Immunoblotting analysis using anti-Myc (Invitro-
gen), anti-APOBEC3G (NIH AIDS Research and Ref-
erence Reagent Program, Catalog no. 9906), anti-β-
actin (Sigma), or anti-HIV-1 Gag p24 (NIH AIDS Re-
search and Reference Reagent Program, Catalog no.
6521) was done essentially as previously described
(16).
Reverse transcriptase (RT) assay
RT assay using 32P-dTTP has been previously de-
scribed (17).
MAGI assay
Infectivity of virions produced in various 293T cell
lines transfected with proviral DNA clones was deter-
mined in MAGI cells as previously described (18).
Immunofluorescence (IF) assay
IF assay has been carried out essentially as previ-
ously described (19). In this study, cells for IF assay
were fixed with ice-cold methanol for 10 min. First
antibody used for this assay was anti-APOBEC3G
(no. 9906).
DNA constructs
An infectious DNA clone of HIV-1 designated
pNL432 (15) and its vif -minus mutant designated
pNL-Nd (11) has been previously described. An ex-
pression vector of human APOBEC3G designated
pcDNA-APO3G (9) and a selection vector designated
pTK-Hyg (Clontech) were used for the establish-
ment of APOBEC3G-positive 293T cell lines.
RESULTS AND DISCUSSION
Most target cells routinely used for HIV-1 infection
are of lymphoid cell lineage, and it is generally diffi-
cult to introduce molecular clones into them by trans-
fection. We were interested in analyzing, by transfec-
tion experiments, the interaction of a cellular innate
anti-retroviral factor APOBEC3G and HIV-1 Vif,
which counteract the activity of APOBEC3G. Recent
availability of the expression vector of APOBEC3G
(pcDNA-APO3G)(9) prompted us to generate mono-
layer cell lines producing APOBEC3G. We selected
293T cell line (12) for this purpose, because its trans-
fection efficiency is exceptionally high and it pro-
duces a huge amount of progeny virions upon trans-
fection of HIV-1 proviral clones.
In order to establish stable cell lines expressing
APOBEC3G, 293T cells were co-transfected by the
calcium-phosphate co-precipitation method (15) with
the pcDNA-APO3G (or pUC19 as control) and pTK-
Hyg at the ratio of approximately 20 : 1, and cultured
in the presence of hygromycin (200μg/ml) for se-
lection. Of numerous cell clones thus obtained, seven
were examined for the expression of APOBEC3G
by Western immunoblotting analysis (Fig. 1A) as pre-
viously described (16). To see the average expres-
sion level, dozens of cell clones were pooled and cul-
tured, and checked also for the APOBEC3G. Quite
unexpectedly, only 4/7 were apparently APOBEC3G-
positive. Among the four clones, two (A3G-C1 and
A3G-C4) showed a higher expression level than that
of the other clones and the pooled sample. The trans-
fection efficiency of these cells were then compared.
The cells were transfected by proviral clones as
above, and RT production into the culture superna-
tants on day 2 post-transfection was determined as
previously described (17). As shown in Fig.1B, no
significant difference in the results was noted. The
observed transfection efficiency for these cells was
similar to that of parental 293T cells (data not shown).
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To determine whether the A3G-C1 and A3G-C4 are
expressing functionally active APOBEC3G, i.e., have
the ability to suppress the replication of HIV-1 with-
out the vif , the infectivity of progeny virions pro-
duced from transfected A3G-C1 and A3G-C4 was
assessed in MAGI cells which are routinely used
as indicator cells for HIV-1 infection (18). As is clear
in Fig. 2, both cell lines consistently expressed bio-
logically active APOBEC3G like naturally occurring
non-permissive cells. In total, based on the results
in Figs. 1 and 2, we concluded that A3G-C1 is the
best clone here.
Next, we comparatively analyzed the expression of
APOBEC3G in lymphocytic H9 cells, natural target
PBMCs and newly established A3G-C1 cells. These
Fig. 1 : Characterization of various 293T clones established in this study. (A) Expressin levels of APOBEC3G in the cell lines es-
tablished by co-transfection of pcDNA-APO3G containing Myc epitope sequence and pTK-Hyg (A3G-C1 to A3G-C8). Lysates were
prepared from the cell lines, and analyzed by immunoblotting using antibodies indicated. Cr, the cell line was obtained by co-
transfection of pUC19 and pTK-Hyg ; P, pooled A3G cell clones. (B) RT production in various cell lines upon transfection of proviral
clones. Each cell clone indicated was transfected with pNL432 or pNL-Nd, and two days later, RT activity in the culture fluids was
determined. Cr and P, the same as above.
Fig. 2 : Viral infectivity of virions produced in various 293T
cell lines. Virus samples were prepared from cells (A3G-C1, A3
G-C4 and Cr) transfected with pNL432 or pNL-Nd, and their in-
fectivity was determined in the MAGI indicator cells (18). Cr,
the same as in Fig.1.
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cells were examined by indirect IF (19) and West-
ern immunoblotting (16) analyses. Fig. 3A shows
the results of the IF assay. Although the intensity
of IF in A3G-C1 cells was much stronger than that
of H9 and PBMC, APOBEC3G predominantly lo-
calized in the cytoplasm of the three cell types as
judged by IF. It was also noted that some cell popu-
lations in A3G-C1 was producing a particularly high
level of APOBEC3G as judged by IF. The biological
meaning of this observation is not presently known.
To quantitatively compare the expression level of
APOBEC3G in various cell types, lysates were pre-
pared from them and subjected to immunoblotting
analysis as shown in Fig. 3B. In good agreement with
the results in Fig. 3A, A3G-C1 expresses far much
higher level of APOBEC3G than that of the others.
We finally monitored the incorporation of
APOBEC3G from A3G-C1 cells into viral particles
in the absence of Vif. A3G-C1 and control 293T cells
were transfected with pNL432 or pNL-Nd, and prog-
eny virions produced on day 2 post-transfection were
collected and concentrated by ultracentrifugation
as previously described (20). As shown in Fig. 4,
quite expectedly, only the virions released from A3G-
C1 cells transfected with the vif -minus mutant clone
contained the APOBEC3G. In addition, we noticed
no abnormal Gag profile in the mutant virions pro-
duced from A3G-C1 cells, suggesting that the Vif
may not affect the virion morphology of HIV-1.
In conclusion in this report, the A3G-C1 cell line,
a newly established 293T subline, was demonstrated
to be very suitable for biological and molecular bio-
logical studies on HIV-1 Vif. It expressed a high level
of APOBEC3G (Figs. 1 and 3). The APOBEC3G
expressed in it was biologically functional (Figs. 2
and 4). Furthermore, it was very sensitive to trans-
fection and produced a high level of HIV-1 virions
(Fig.1). By using A3G-C1 cells, we would be able to
analyze the molecular basis for interaction of HIV-
1 Vif and APOBEC3G more easily and definitely.
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Fig. 4 : Incorporation of APOBEC3G into HIV-1 virions pro-
duced in the absence of Vif. Virus particles were prepared from
293T cells and A3G-C1 transfected with pNL432 (+) or pNL-Nd
(-) as previously described (20), and their lysates were made
for immunoblotting analysis. For detection of APOBEC3G and viral
p24, anti-APOBEC3G (no. 9906) and anti-Gag p24 (no. 6521) an-
tibodies, respectively, were used.
Fig. 3 : Expression of APOBEC3G in 293T/A3G-C1, 293T/A3
G-C8, H9 and PBMC cultures. Expression of APOBEC3G in
various cell types was monitored by indirect IF (A) and im-
munoblotting (B) assays. A3G-C8 was used as a negative control
(see Fig.1). (A) For detection of APOBEC3G, anti-APOBEC3G
(no. 9906) and FITC-conjugated anti-rabbit IgG antibodies were
used as 1st and 2nd antibodies, respectively. (B) For detection
of APOBEC3G, anti-APOBEC3G antibody (no. 9906) was used.
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